- Title
- P-2036. Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study
- Creators
- Onyema Ogbuagu - ,Jason D Goldman - Swedish Medical CenterRobert L Gottlieb - Baylor University Medical CenterUpinder Singh - Stanford UniversityMasaharu Shinkai - New Tokyo HospitalGerard Acloque - ,Dahlene Fusco - Tulane UniversityErika Gonzalez - ,Princy N Kumar - Georgetown University Medical CenterAnnie Luetkemeyer - University of California, San FranciscoAmos Lichtman - Gilead SciencesAfsaneh Mozaffarian - Gilead SciencesYiannis Koullias - Gilead SciencesRobert H Hyland - Gilead SciencesJoe Llewellyn - Gilead SciencesAnu Osinusi - Gilead SciencesFrank Duff - ,Rita Humeniuk - Gilead SciencesLuzelena Caro - Gilead SciencesSantosh Davies - Gilead SciencesCharlotte Hedskog - Gilead SciencesShuguang Chen - Gilead SciencesKim Etchevers - Gilead SciencesPriyanka Nadig - ,Anita Kohli - Arizona Liver Health
- Publication Details
- Open forum infectious diseases, Vol.12(Suppl 1)
- Publisher
- Oxford University Press
- Identifiers
- 991006142642702656
- Academic Unit
- Internal Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
P-2036. Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study
Open forum infectious diseases, Vol.12(Suppl 1)
01/29/2025
Metrics
1 Record Views